HomeACTU • NASDAQ
add
Actuate Therapeutics Inc
Previous close
$9.00
Day range
$8.75 - $9.00
Year range
$5.52 - $10.16
Market cap
175.39M USD
Avg Volume
51.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.39M | -16.72% |
Net income | -5.97M | 5.79% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.52M | — |
Total assets | 14.26M | — |
Total liabilities | 8.90M | — |
Total equity | 5.36M | — |
Shares outstanding | 19.53M | — |
Price to book | 33.33 | — |
Return on assets | -168.60% | — |
Return on capital | 411.13% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.97M | 5.79% |
Cash from operations | -9.15M | -62.27% |
Cash from investing | — | — |
Cash from financing | 22.32M | — |
Net change in cash | 13.17M | 333.61% |
Free cash flow | -8.59M | — |
About
Founded
2015
Headquarters
Website
Employees
11
